The Exposome is Everything in Atopic Dermatitis: An Expert Perspective on AD Pathophysiology
Raj Chovatiya, MD, PhD, MSCI, discusses the complex and widely variable influences that affect the manifestations and burden of atopic dermatitis across populations.
Universal ED Syphilis Screening Outperforms Targeted Approaches, Study Shows
CROI 2025: Researchers reported that a universal syphilis screening program identified more cases than programs targeting specific patient populations.
AGA: AI-Assisted Colonoscopy Increases Adenoma Detection, But Long-Term Benefits Unclear
New AGA guidelines conclude that it is not clear whether computer-aided detection systems for colonoscopy should be recommended for routine widespread use.
Melanin Isn't Everything: Skin Physiology Does Not Conform to Socially Defined Variables, Explains Raj Chovatiya, MD, PhD, MSCI
AAD 2025: Chovatiya discusses whether melanin concentration plays a role in skin physiology and cautioned against typing with factors that are not true biologic constructs.
Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose
Your daily dose of the clinical news you may have missed.
Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV
CROI 2025: Increased HPV vaccine coverage could reduce HIV cases by thousands, according to a new study.
US Adult Vaccination Snapshots: Current Coverage, Trends, and Concerns
Get the latest immunization updates, data on racial disparities, and practical guidance for clinical practice, here.
Massive Trump Administration Cuts to Federal Grants Halt National Diabetes Prevention Program
The 30-year program has tracked and compiled data on diabetes prevention, treatment, and outcomes, providing a foundation and insights for international research.
ZUPREME-1 Phase 2b Trial of Petrelentide for Obesity Completes Enrollment
The amylin analog at 5 doses will be compared with placebo when added to a reduced calorie diet and increased physical activity regimen for 42 weeks, said Zealand Pharma.
Roflumilast Cream Shows Strong Tolerability in Patients with AD Failing Other Topicals: Daily Dose
What We Mean When We Say "Skin of Color" in Dermatology: A Closer Look with Raj Chovatiya, MD, PhD, MSCI
Chovatiya, expert clinical dermatologist and researcher, points out that the term "skin of color" comprises a heterogenous set of topics, in an interview at AAD 2025.
Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care
In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.
Antibiotics, NSAIDs Reported Most Common Cause of Pediatric Anaphylaxis
Among pediatric patients aged 1 month to 18 years with emergent anaphylaxis, cephalosporins were the leading antibiotics and ibuprofen the top NSAID implicated in a new study.
Osteoporosis Risk Screening Tools Fall Short in Younger Postmenopausal Women, New Research Reveals
Three of the 5 osteoporosis screening tools recommended by the USPSTF for identifying osteoporosis in postmenopausal women aged 50 yo 64 years proved suboptimal.
Topical Steroid Withdrawal: Study Identifies Mitochondrial Dysfunction as a Potential Target for Treatment
NIH researchers also proposed new diagnostic criteria that include a combination of major and minor symptoms, offering improved sensitivity for identifying TSW cases.
FDA Greenlights First Rivaroxaban Generics (2.5 mg): Daily Dose
Antihistamines Are a Poor Option to Treat Eczema in Older Adults: Clinical Pearl
Antihistamines for itch caused by disorders like atopic dermatitis pose more problems, like sedation and fall risk, than they provide relief, according to Daniel Butler, MD.
Early Responsive Parenting Intervention Shows Modest, Short-Term Impact on Childhood Obesity
New data shows that early-life responsive parenting can lower childhood BMI, but effects diminished by age 9, highlighting the need for ongoing obesity prevention efforts.
Povorcitinib Efficacy in 2 Pivotal Phase 3 Trials Will Support Global Regulatory Submission for Hidradenitis Suppurativa
Both trials met their primary endpoints, demonstrating a statistically significant improvement in HiSCR50 compared to placebo, with a favorable safety profile, according to Incyte.
Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy
Elizabeth Swanson, MD, shares how the rise of T.indotineae, a terbinafine-resistant fungal species, has shifted her treatment approach.
